Drospirenone Lactol Impurity is chemically (2'S,6R,7R,8R,9S,10R,13S,14S,15S,16S)-1,4',5',6,7,8,9,10,11,12,13,14,15,16,20,21-Hexadecahydro-5'-hydroxy-10,13-dimethyl-spiro[17H-dicyclopropa[6,7:15,16]cyclopenta[a]phenanthrene-17,2'(3'H)-furan]-3(2H)-one. It is also known as 5’-Hydroxy Drospirenone. Drospirenone Lactol Impurity is supplied with detailed characterization data compliant with regulatory guideline. Drospirenone Lactol Impurity can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Drospirenone.
關(guān)鍵字： 醫(yī)藥對(duì)照品;
祥根生物醫(yī)藥于2008年12月成立，是一家集藥物研發(fā)、生產(chǎn)、銷售的創(chuàng)新型醫(yī)藥高科技企業(yè)，榮獲“國家高新技術(shù)企業(yè)”和“博士后實(shí)踐創(chuàng)新基地”等稱號(hào)。祥根生物醫(yī)藥擁有藥物成分標(biāo)準(zhǔn)物質(zhì)、關(guān)鍵中間體、原料藥與藥品進(jìn)出口全產(chǎn)業(yè)鏈平臺(tái)。祥根是眾多全球知名標(biāo)準(zhǔn)品（Aozeal/USP/EP/LGC/Bachem/TLC/TRC/SynZeal/意大利試劑等）和原料藥（INKE/Bachem/瑞迪/意迪那等）總代理和授權(quán)代理商，處于行業(yè)領(lǐng)先水平。
祥根生物醫(yī)藥擁有一個(gè)尊重人才、重視績(jī)效、持續(xù)創(chuàng)新的平臺(tái)。 研發(fā)團(tuán)隊(duì)由多名海外高層次人才領(lǐng)銜，研發(fā)人員50余人；獲得相關(guān)發(fā)明專利30余項(xiàng)。祥根生物醫(yī)藥的企業(yè)責(zé)任是：回報(bào)員工、回報(bào)合作伙伴、回報(bào)社會(huì)；企業(yè)愿景是：提升藥品質(zhì)量，保護(hù)人類健康。